ArticleScientific reports2025
Faster referral and surgical intervention for rhegmatogenous retinal detachment during COVID-19: a comparison of pre- and during-pandemic cases.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the impact of the COVID-19 pandemic on the incidence and clinical characteristics of rhegmatogenous retinal detachment (RRD) patients referred to a high-volume center, Farabi Eye Hospital, Iran. In a retrospective study, all new RRD patients referred to Farabi Eye Hospital between March 2019 and March 2020 (pre-pandemic, Group 1) and March 2020 and March 2021 (post-pandemic, Group 2) were analyzed. The groups were compared based on demographic and clinical data. A total of 375 patients were included (131 pre-pandemic, 244 post-pandemic, and 34 during lockdowns). The during-pandemic group had a shorter referral time (44.97 vs. 76.76 days, p = 0.031) and surgical wait time (4.64 vs. 8.63 days, p < 0.001). No significant differences were found in pre-operative features (etiology, proliferative vitreoretinopathy, break type), surgical procedures, or initial treatment failure rates between the groups. General anesthesia use was significantly higher in the during-pandemic group (81.6% vs. 71.8%, p = 0.029). The COVID-19 pandemic did not significantly alter the demographic, clinical characteristics, or initial surgical outcomes of RRD patients. However, patients were referred and treated more expeditiously during the pandemic. The increased use of general anesthesia requires further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.